AIM Rule 17 – Schedule 2(g) update

Source: RNS
RNS Number : 1295N
Livermore Investments Group Limited
27 May 2022

27 May 2022


("Livermore" or the "Company")

AIM Rule 17 - Schedule 2(g) update


As part of Strand Hanson Limited's ongoing onboarding due diligence, Livermore notifies the following update in relation to directors' disclosure for Noam Lanir, Chief Executive Officer of the Company, pursuant AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

On 22 September 2016, the Administrative Enforcement Committee of the Israel Securities Authority ("the ISA") certified an enforcement arrangement between the ISA and Babylon Limited ("Babylon"), a company listed on the Tel Aviv Stock Exchange, and its officers Alon Carmeli, Noam Lanir, and Shanit Peer Zefoni (the "respondents"). Under the arrangement, Babylon and Carmeli were attributed negligent reporting violations, and negligent inclusion of misstatements in periodic reports was attributed to all respondents. The respondents admitted to the facts stated in the arrangement but did not admit to the commission of the violations. Under the arrangement, a NIS 1 million fine was imposed on Babylon, which undertook to redefine its procedure for issuing immediate reports. A fine of NIS 250,000 was imposed on Alon Carmeli and he was prohibited to serve as a senior officer in a supervised entity for a period of five months. A fine of NIS 150,000 and suspended prohibition to serve as an officer for six months was imposed on Noam Lanir. A fine of NIS 75,000 was imposed on Shanit Peer Zefoni.

Mr Lanir remained Chairman of the Board of Directors of Babylon following the arrangement.


For further information please contact: 

Livermore Investments Group Limited

+41 (0) 43 344 3200

Gaurav Suri


Strand Hanson Limited (Financial and Nominated Adviser)

+ 44 (0) 20 7409 3494

Richard Johnson, Ritchie Balmer, James Spinney


Arden Partners plc (Broker)

  +44 (0) 20 7614 5900



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.